2021
DOI: 10.1097/01.ccm.0000809400.23326.8a
|View full text |Cite
|
Sign up to set email alerts
|

769: Comparison of 4f-PCC and Andexanet Alfa for Reversal of Apixaban- And Rivaroxaban-Associated Ich

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles